Condition
Hyperglycaemia (Diabetic) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Hyperglycaemia (Diabetic) clinical trials that are recruiting, at sites in 4 countries (most in United States (1), China (1), Taiwan (1)). By phase: Phase 1/2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Hyperglycaemia (Diabetic) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Digital health platform to help prevent and manage high blood pressure, lipids, and kidney and heart disease | — | New Taipei City | Recruiting | May 14, 2026 |
| Intravenous arginine to help treat diabetic ketoacidosis in people with type 2 diabetes | Phase 1/2 | Detroit, Michigan | Recruiting | Sep 11, 2025 |
| Blood and OCT biomarkers in people with diabetic macular edema receiving anti-VEGF or dexamethasone implant | — | Mölndal and 1 other locations | Recruiting | May 22, 2025 |
| Comparing Liraglutide and Insulin Glargine for Type 2 Diabetes Management | Phase 4 | Xiamen, Fujian | Recruiting | Mar 22, 2017 |
All recruiting trials (4)
-
Digital health platform to help prevent and manage high blood pressure, lipids, and kidney and heart disease
This trial tests a mobile digital health platform to help people with hypertension, dyslipidemia, and related conditions in New Taipei City see if the platform improves blood pressure, cholesterol, and kidney health.
-
Intravenous arginine to help treat diabetic ketoacidosis in people with type 2 diabetes
This study tests whether a single IV dose of arginine given early in DKA can safely boost your own insulin and help adults with ketone-prone type 2 diabetes recover faster.
-
Blood and OCT biomarkers in people with diabetic macular edema receiving anti-VEGF or dexamethasone implant
This project will test whether blood markers and OCT imaging signs can predict how people with diabetic macular edema respond to anti-VEGF injections or a dexamethasone eye implant.
-
Comparing Liraglutide and Insulin Glargine for Type 2 Diabetes Management
This study is testing if adding a medication called Liraglutide to insulin can help overweight and obese people with uncontrolled type 2 diabetes manage their blood sugar better and avoid weight gain compared to using a different type of insulin alone.
Related topics
Quick answers
How many Hyperglycaemia (Diabetic) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (1 trial), China (1 trial), Taiwan (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.